vimarsana.com

Latest Breaking News On - Lixu - Page 1 : vimarsana.com

Nasdaq Helsinki Ltd: Final result of DNV s Voluntary Recommended Public Cash Tender Offer for all Shares and Stock Options in Nixu: DNV Completes the Tender Offer

Final result of DNV's Voluntary Recommended Public Cash Tender Offer for all Shares and Stock Options in Nixu: DNV Completes the Tender Offer DNV, Press Release, June 8, 2023, 12.00 p.m. EET NOT FOR

Eteläuomen läiMecklenburg vorpommernUnited statesRobert coveneyLeena viitanenStefan klotterAnniina hautakoskiFinnish companiesDanish financial supervisory authorityDanske bankDisclaimer nordea bank abpUs securities exchangeFinland branchAdvisors nordea bank abpNixu corporationNasdaq helsinki ltd

Nasdaq Helsinki Ltd: Preliminary Result of DNV s Voluntary Recommended Public Cash Tender Offer for all Shares and Stock Options in Nixu

Preliminary Result of DNV's Voluntary Recommended Public Cash Tender Offer for all Shares and Stock Options in Nixu DNV, Press Release, June 6, 2023, 12.00 p.m. EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION

United statesMecklenburg vorpommernEteläuomen läiStefan klotterLeena viitanenRobert coveneyAnniina hautakoskiMiltton ltdDanske bankBorenius attorneys ltdWhite caseFinland branchUs securities exchangeDanish financial supervisory authorityNordea bank abpNasdaq helsinki ltd

China Digest: Lynk Pharma, Bestzyme Bioengineering bag funds

Biopharmaceutical firm Lynk Pharmaceuticals has bagged 200 million yuan ($28.2 million) in its Series C1 round, according to a release.

Hong kongHong kong stock exchange onChina lynk pharmaceuticalsDaoxing entrepreneurship investment management centerLynk pharmaceuticalsLiandong investment groupBestzyme bioengineeringChina grand prosperity investmentHangzhou based tailong venture capitalLiandou valleyLilly asiaHong kong listed genscript biotechHong kong stock exchangeGenscript biotechHuatai zijin investmentHong kong listed huatai securities

Nasdaq Helsinki Ltd: DNV Extends the Offer Period for the Voluntary Recommended Public Cash Tender Offer for all Shares and Stock Options in Nixu

DNV Extends the Offer Period for the Voluntary Recommended Public Cash Tender Offer for all Shares and Stock Options in Nixu DNV, Press Release, May 2, 2023, 1:00 p.m. EET NOT FOR RELEASE, PUBLICATION

United statesEteläuomen läiAnniina hautakoskiRobert coveneyLeena viitanenNordea bank abpDisclaimer nordea bank abpDanske bankFinland branchBorenius attorneys ltdExchange commissionAdvisors nordea bank abpWhite caseMinistry of economic affairsUs securities exchangeMiltton ltd

Nasdaq Helsinki Ltd: DNV Supplements the Tender Offer Document Relating to the Voluntary Recommended Public Cash Tender Offer for all Shares and Stock Options in Nixu

DNV, Press Release, April 21, 2023, 1.00 p.m. EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND

Eteläuomen läiUnited statesAnniina hautakoskiRobert coveneyLeena viitanenFinnish financial supervisory authorityBorenius attorneys ltdDanish financial supervisory authorityNixu corporationMiltton ltdAdvisors nordea bank abpUs securities exchangeDisclaimer nordea bank abpNordea bank abpFinland branchDanske bank

vimarsana © 2020. All Rights Reserved.